Brief: Orthofix Medical Q2 Sales USD 198.6 Million Vs. IBES Estimate USD 195.2 Million
Aug 06 (Reuters) - Orthofix Medical Q2 gross margin 67.8%. * Q2 adjusted EBITDA USD 16.6 million
Recent news on Orthofix Medical
See all newsOrthofix Medical Inc. reports results for the quarter ended June 30 - Earnings Summary
Orthofix Medical Q2 sales slightly beat estimates
Orthofix Medical Inc expected to post a loss of 41 cents a share - Earnings Preview
Orthofix Medical Q1 sales beat estimates, reaffirms FY outlook
Brief: Orthofix Medical Inc - Announces Strategic Realignment Of Spine Leadership Team